Skip to content
Stox
Stox

Indian (NSE) stock fundamentals, results & shareholding

HISTORICAL Post-Result Price Performance
Return so far since result
▲+1.48%
Window still open — 8 of 90 days elapsed since the result date.
📅 Window: 04 Nov 26 → 02 Feb 27
MODEL ESTIMATE Next 90 days
Estimated price change
+5.3% → ₹ 1,599.71
Likely range: -9.7% to +17.5%
From ₹ 1,519.60 on 09 Nov 26. Past accuracy: the actual move fell inside the range in 62.4% of 1506 closed windows; direction right 35.2% of the time.
For information only — not investment advice and not a recommendation to buy, sell or hold.
📊 Rolling Returns 15 days : 3.9 % 3 months : -7.7 % 6 months : -22.5 % 1 year : -39 %

Quarterly Results

Date of Result04 Nov 202606 Aug 202613 May 202602 Feb 202606 Nov 202507 Aug 202519 Sep 202605 Feb 202529 Oct 202413 Sep 2024
Reported QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Sales505.38459.65503.62522.52491.09380.77463.51363.62323.28303.42
Other Income4.4335.087.6169.937.075.664.952.96
Expenses468.93425.09455.09476.78453.59352.93420.2331.77300.79279.02
Profit Before Tax40.8937.5553.650.1143.537.7850.3937.5127.4427.36
TaxExpense10.29.311712.8411.229.411.719.316.777.08
Net Profit30.6928.2536.637.2632.2828.3838.6828.220.6720.28
Basic EPS in ₹18.2716.8421.8222.2219.2517.0523.2516.9413.5414.07
Total Income509.81462.65508.7530.13497.09390.7470.58369.28328.23306.38
Operating Profit36.4534.5648.5345.7437.527.8443.3131.8522.4924.4
OPM%7.217.529.648.757.647.319.348.766.968.04
Operating Profit QoQ %5.47-28.796.121.9734.7-35.7235.9841.62-7.83-
Operating Profit YoY %-2.824.1412.0543.6166.7414.1----
OPM% QoQ %-4.12-21.9910.1714.534.51-21.736.6225.86-13.43-
OPM% YoY %-5.632.873.21-0.119.77-9.08----
Sales QoQ %9.95-8.73-3.626.428.97-17.8527.4712.486.55-
Sales YoY %2.9120.728.6543.751.9125.49----
Net Profit QoQ %8.64-22.81-1.7715.4313.74-26.6337.1636.431.92-
Net Profit YoY %-4.93-0.46-5.3832.1356.1739.94----

Annual Results

Date of Result13 May 202619 Sep 2026
Reported QuarterMar 2026Mar 2025
Sales18981453.83
Other Income28.6320.65
Expenses1738.391331.78
Profit Before Tax184.99142.7
TaxExpense50.4734.87
Net Profit134.52107.83
Basic EPS in ₹80.4168.51
Operating Profit159.61122.05
OPM%8.418.4
ROCE%951.76733.47
ROE%802.15648.02
Debt to Equity0.891.03
Operating Profit YoY %30.77-
OPM% YoY %0.12-
Sales YoY %30.55-
Net Profit YoY %24.75-
Debt to Equity (screener)0.02040.0266
Borrowings (screener)1820
Equity (screener)881752
de_sourcescreenerscreener

Shareholding Pattern

Date of Report12 Oct 202621 Jul 202618 Apr 202609 Jan 202618 Jul 202519 Apr 202510 Jan 202530 Sep 2024
Pledge %00000000
Promoters59.2759.4359.4359.4359.959.959.959.9
FIIs14.0713.6614.4817.6913.9211.9914.298.9
DIIs5.336.15.164.016.986.516.8615.52
Public40.7340.5740.5740.5740.140.140.140.1
Promoters QoQ %-0.1600-0.47000-
Promoters YoY %--0.47-0.47-0.47----
Public QoQ %0.16000.47000-
Public YoY %-0.470.470.47----
DIIs QoQ %-0.770.941.15-2.970.47-0.35-8.66-
DIIs YoY %--0.88-1.35-2.85----
FIIs QoQ %0.41-0.82-3.213.771.93-2.35.39-
FIIs YoY %--0.262.493.4----

Found Stox useful? Share the free NSE screener with a friend. Shares a link to the tool only — educational, not investment advice.

More from CryoSim

About Stox, the free NSE stock screener & results tracker How to use Stox, step by step

Privacy Policy Terms of Use Disclaimer Contact
Disclaimer: For information and education only. Not investment advice, and not a recommendation to buy, sell or hold any security. Grades, ranks, post-result price performance and 90-day model estimates are produced automatically from public market and company data. Model estimates are statistical, frequently wrong, and are not price targets or recommendations. CryoSim is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future returns. Investments in securities are subject to market risks; read all related documents carefully and consult a SEBI-registered adviser before investing. Stox is not liable for any financial losses or market risks.
© 2026 Stox. All rights reserved.